Anil Kapoor1, Naji J Touma, Regina El Dib. 1. Chair, GU Oncology Program, Juravinski Cancer Centre, Professor of Surgery (Urology), St. Joseph's Healthcare, McMaster University, Hamilton, ON;
Abstract
PURPOSE: Small renal masses are increasingly being discovered incidentally on imaging for another reason. The standard of care of these masses involves excision by open or laparoscopic techniques. Recently, ablative techniques, such as radiofrequency ablation (RFA) and cryoablation, have taken a more prominent role in the treatment algorithm of these masses. We evaluate the effectiveness and safety of cryoablation to treat renal tumours. METHODS: A review of the literature was conducted. There was no language restriction. Studies were obtained from the following sources: the Cochrane Library, PUBMED, EMBASE and LILACS. RESULTS: There was no clinical trial identified in the literature. Thus, we described the results from 23 case series and retrospective studies with a reasonable sample size (number of reported patients in each study ≥30), with a total of 2104 analyzed tumours from 2038 patients. There was wide variability in the outcomes reported, but success rates were generally good. Follow-up was generally short, but some series reported outcomes at 5 years. The most common complications reported were hemorrhage (some of the patients requiring transfusion), perinephric hematoma and urine leaks. CONCLUSION: Cryoablation presents a feasible treatment for patients with small renal masses. Only short-term data are available and, as such, meaningful conclusions regarding long-term cancer control cannot be made. More rigorous studies are needed.
PURPOSE: Small renal masses are increasingly being discovered incidentally on imaging for another reason. The standard of care of these masses involves excision by open or laparoscopic techniques. Recently, ablative techniques, such as radiofrequency ablation (RFA) and cryoablation, have taken a more prominent role in the treatment algorithm of these masses. We evaluate the effectiveness and safety of cryoablation to treat renal tumours. METHODS: A review of the literature was conducted. There was no language restriction. Studies were obtained from the following sources: the Cochrane Library, PUBMED, EMBASE and LILACS. RESULTS: There was no clinical trial identified in the literature. Thus, we described the results from 23 case series and retrospective studies with a reasonable sample size (number of reported patients in each study ≥30), with a total of 2104 analyzed tumours from 2038 patients. There was wide variability in the outcomes reported, but success rates were generally good. Follow-up was generally short, but some series reported outcomes at 5 years. The most common complications reported were hemorrhage (some of the patients requiring transfusion), perinephric hematoma and urine leaks. CONCLUSION: Cryoablation presents a feasible treatment for patients with small renal masses. Only short-term data are available and, as such, meaningful conclusions regarding long-term cancer control cannot be made. More rigorous studies are needed.
Authors: Kyle J Weld; Robert S Figenshau; Ramakrishna Venkatesh; Sam B Bhayani; Caroline D Ames; Ralph V Clayman; Jaime Landman Journal: Urology Date: 2007-03 Impact factor: 2.649
Authors: I S Gill; A C Novick; A M Meraney; R N Chen; M G Hobart; G T Sung; J Hale; D K Schweizer; E M Remer Journal: Urology Date: 2000-11-01 Impact factor: 2.649
Authors: Christopher J Weight; Jihad H Kaouk; Nicholas J Hegarty; Erick M Remer; Charles M O'Malley; Brian R Lane; Inderbir S Gill; Andrew C Novick Journal: J Urol Date: 2008-02-20 Impact factor: 7.450
Authors: Eric J Lawatsch; Peter Langenstroer; Gregory F Byrd; William A See; Francisco A Quiroz; Frank P Begun Journal: J Urol Date: 2006-04 Impact factor: 7.450
Authors: Thomas D Atwell; Michael A Farrell; Matthew R Callstrom; J William Charboneau; Bradley C Leibovich; Igor Frank; David E Patterson Journal: AJR Am J Roentgenol Date: 2007-05 Impact factor: 3.959
Authors: R Damm; T Streitparth; P Hass; M Seidensticker; C Heinze; M Powerski; J J Wendler; U B Liehr; K Mohnike; M Pech; J Ricke Journal: Strahlenther Onkol Date: 2019-07-25 Impact factor: 3.621
Authors: Roberto Luigi Cazzato; Julien Garnon; Nitin Ramamurthy; Guillaume Koch; Georgia Tsoumakidou; Jean Caudrelier; Francesco Arrigoni; Luigi Zugaro; Antonio Barile; Carlo Masciocchi; Afshin Gangi Journal: Med Oncol Date: 2016-11-11 Impact factor: 3.064